AI-driven biotech is becoming a strategic technology frontier, tightening the link between technology controls and AML transparency.
Scan below QR to join the Zoom on that day, 18th November, 7pm.

AI-driven biotech is becoming a strategic technology frontier, tightening the link between technology controls and AML transparency.
Scan below QR to join the Zoom on that day, 18th November, 7pm.

